The DOI matches its Crossref record; 72 of the 73 references it cites were found in a registry or an index; 11 of the 47 sources its claims cite were checked for support.
Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism
Open accessAbstract
Despite the crucial role of the liver in glucose homeostasis, a detailed mathematical model of human hepatic glucose metabolism is lacking so far. Here we present a detailed kinetic model of glycolysis, gluconeogenesis and glycogen metabolism in human hepatocytes integrated with the hormonal control of these pathways by insulin, glucagon and epinephrine. Model simulations are in good agreement with experimental data on (i) the quantitative contributions of glycolysis, gluconeogenesis, and glycogen metabolism to hepatic glucose production and hepatic glucose utilization under varying physiological states. (ii) the time courses of postprandial glycogen storage as well as glycogen depletion in overnight fasting and short term fasting (iii) the switch from net hepatic glucose production under hypoglycemia to net hepatic glucose utilization under hyperglycemia essential for glucose homeostasis (iv) hormone perturbations of hepatic glucose metabolism. Response analysis reveals an extra high capacity of the liver to counteract changes of plasma glucose level below 5 mM (hypoglycemia) and above 7.5 mM (hyperglycemia). Our model may serve as an important module of a whole-body model of human glucose metabolism and as a valuable tool for understanding the role of the liver in glucose homeostasis under normal conditions and in diseases like diabetes or glycogen storage diseases.
Overview
CoChat Summary
TL;DR
The paper presents a detailed kinetic model of human hepatic glucose metabolism integrating insulin, glucagon, and epinephrine control via enzyme phosphorylation state. Model simulations reproduce experimental data on hepatic glucose production/utilization, glycogen storage and depletion, fasting, and hormone perturbations, and reveal high hepatic counter-regulatory capacity below 5 mM and above 7.5 mM glucose.
Key findings
- The liver switches between net hepatic glucose production (HGP) and net hepatic glucose utilization (HGU) at a set point of 6.6 mM glucose for half-filled glycogen stores, varying from 5.4 mM for empty to 7.5 mM for filled stores; the gluconeogenesis/glycolysis set point is 8.5 mM for half-filled glycogen, and the glycogenesis/glycogenolysis set point is 5.1 mM.
- In short-term fasting, HGP decreases to a constant basal rate of 7–8 µmol/kg(bw)/min around 40 h; after an overnight fast about half of HGP comes from glycogenolysis, whereas after 40 h fasting only 10% comes from glycogen and 90% from gluconeogenesis. The model predicts ∼8.5 µmol/kg(bw)/min HGP for 20 h at 3 mM glucose with 95% from gluconeogenesis, compared with experimental values of 7.56–9.8 µmol/kg(bw)/min HGP and 92–97% gluconeogenesis.
- Hormone perturbation simulations show that insulin and glucagon depletion or glucagon depletion alone reduce HGP to around 70% of basal values, while insulin depletion increases HGP to around 130%; basal glucagon is responsible for about 30% of HGP.
- The hepatic glucose response coefficient indicates an extra high capacity to counteract plasma glucose changes below 5 mM (hypoglycemia) and above 7.5 mM (hyperglycemia), with high-response regions below 4 mM and above 8 mM glucose.
Methods
- The model consists of 49 localized metabolites and 36 reactions compartmentalized into cytosol, mitochondrion, and blood, with individual kinetics for reactions and transporters; it includes allosteric regulation and hormonal regulation via phosphorylation/dephosphorylation of interconvertible enzymes (GS, GP, PFK2, FBP2, PK, and PDH).
- Experimental flux data were human-specific, metabolite concentrations were taken from human and rat liver, HGP/gluconeogenesis/glycogenolysis data came from 25 independent studies, and hormone glucose-response curves were fitted to oral glucose tolerance tests and hypoglycemic, hyperinsulinemic clamp studies.
- The differential equation system was integrated with MATLAB ode15s; steady-state and quasi-steady-state simulations varied blood glucose from 2 to 14 mM and glycogen from 0 to 500 mM, with metabolic control analysis and hepatic glucose response coefficient calculations.
Limitations
- The paper states that hormone signal transduction is phenomenological due to lack of quantitative signaling data; cellular redox and energy states are held constant; the model represents an “average” hepatocyte and neglects metabolic zonation; gene expression changes are not included; and the phosphorylation state of all regulatory enzymes is assumed equal and instantaneous.
- The paper also notes that the model comprises fairly active futile cycles in glycogen metabolism, the PFK1/FBPase1 system, and between PEPCK and PK, and that it is not able to simulate conditions where energy decoupling is invalid, such as hypoxic or ischemic conditions.
- Evident from the text: external blood glucose and lactate concentrations were kept fixed in all simulations, and gluconeogenic substrates other than lactate were neglected.
Model-written summary. Check it against the paper before relying on it.
Integrity signals
Registry
Cites
Statistics
Figures



![Figure 4 Glycogen metabolism and hormone perturbations. (A) Decrease in glycogen during short term fasting over 60 h. Experimental data from [22] (individual data) and [23] (mean data with STD) given in Dataset S1. Simulation time courses (dashed lines) start from filled glycogen stores (500 mM). Blood glucose is varied between 3.6 mM (red) and 5.0 mM (green) in steps of 0.2 mM (black). The blue curve corresponds to a situation where the plasma glucose concentration changes from initially 5 mM to 3.6 mM in 60 h. Higher blood glucose results in a slower decrease in glycogen. (B) Increase in glycogen after a glucose load. Experimental data from [8], [24], [25] given in Dataset S1. Simulation time courses (dashed lines) start from initial glycogen concentration of 200 mM. Blood glucose concentrations are varied between 5.5 mM (red) and 8.0 mM (green) in steps of 0.5 mM (black). The blue line corresponds to 7 mM. Higher blood glucose results in a faster increase in glycogen after a glucose load. (C) Change in HGP and plasma glucose in insulin deficiency. Insulin (blue) and glucagon (red) time courses for an idealized hormone perturbation (left), the experimental data from [27] (middle), and a simulation taking the experimental profile of hormones and glucose utilization into account are shown in the top row. Middle row depicts the time courses of HGP (red) and whole-body glucose utilization GU (black). Bottom row shows the resulting change in plasma glucose as a consequence of the changes in HGP. Insulin deficiency increases HGP relative to GU resulting in an increase in plasma glucose. After insulin normalization HGP decreases and falls below GU due to the increased blood glucose. (D) Changes in HGP during the infusion period (135–200 min) relative to the pre-infusion period (85–135 min) for the simulations and experiments and the various hormone perturbations. Saline infusion (Figure S1) and somatostatin infusion with insulin and glucagon restauration (Figure S5) have no effect on basal HGP. Insulin and glucagon deficiency (Figure S2) and glucagon deficiency alone (Figure S3) decrease HGP relative to basal values. Insulin deficiency increases basal HGP (Figure 4C, Figure S4).](https://figures.cochat.ai/paper-figures/87490a05018a4b85974b7ba672eac06d/quantifying-the-contribution-of-the-liver-to-glucose-homeostasis-a-detailed-figure-4.jpg)
![Figure 5 HGP/HGU and HGRC. Steady state solution of time course simulations under constant glycogen and blood glucose concentration (every data points correspond to a single simulation to steady state). Glycogen is varied between 0 and 500 mM in steps of 5 mM, blood glucose is varied between 2 and 14 mM in steps of 0.05 mM. (A) HGP (red)/HGU (green) ([]) corresponding to GLUT2 flux. The liver switches between HGP and HGU depending on the blood glucose and glycogen. The set point varies between 5.4 mM for empty and 7.5 mM for completely filled glycogen stores (6.6 mM at glycogen 250 mM). (B) HGRC ([]). Response of the liver to changes in the blood glucose. Two main regions of high response exist: A hypoglycemic region below 4 mM, and a hyperglycemic region above 8 mM glucose. (C) gluconeogenesis (red)/glycolysis (green) ([]) corresponding to glucose-6p isomerase (GPI) flux. The gluconeogenesis/glycolysis set point varies between 8.8 mM for empty and 7.0 mM for filled glycogen stores. (D) glycogenolysis (red)/glycogenesis (green) ([]) corresponding to flux through glucose-1p isomerase (G1PI).](https://figures.cochat.ai/paper-figures/4d457956c15a4280b6d22553178050f2/quantifying-the-contribution-of-the-liver-to-glucose-homeostasis-a-detailed-figure-5.jpg)
Verification
Claims the paper makes
10 Valid · 0 Not valid · 19 Not checked · 112 Own results and interpretations
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The simulations for short term fasting under constant glucose concentrations between 5 mM (green) and 3 mM (red), the normal range of fasting glucose concentration [22], [23], are in agreement with the experimental data (Figure 3, Table 2).”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > HGP, gluconeogenesis and glycogenolysis in short term fasting
What the sources say
- Not checked — no full text of the sourcecites [22] DL Rothman, 1991, Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR., Science source
- Partly supportedcites [23] I Magnusson, 1992, Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., J Clin Invest sourceExperimental — accuracy not yet measured
The citation is attached to the description of 3–5 mM as the normal fasting-glucose range, not to the citing authors’ conclusion about their simulations. Table I in the Results reports fasting plasma glucose of 5.4 ± 0.2 and 5.1 ± 0.2 mmol/L in healthy controls after 16 and 23 hours, respectively, but does not establish 3 mM as a normal lower bound. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“To further evaluate the predictive capacity of our model, we performed time-course simulations of experimentally determined glycogen levels in dogs monitored under conditions of hyperglycemic, hyperinsulinemic clamps and administration of a mixed meal diet [26], as can be seen from the respective figures in the supplement (Figure S1, S2, S3, S4, S5, S6), our model simulation were in good agreement”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Glycogen synthesis postprandial
What the sources say
- Partly supportedcites [26] M Krssak, 2004, Alterations in postprandial hepatic glycogen metabolism in type 2 diabetes., Diabetes sourceExperimental — accuracy not yet measured
The Research Design and Methods section describes human participants, not dogs, in both the mixed-meal and clamp protocols. Figure 3 reports measured hepatic glycogen time courses for those participants under both conditions. The cited paper therefore supports the use of experimental glycogen time courses, but not their attribution to dogs; the citing authors' model agreement is their own conclusion. (LLM, conf=0.90)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 6 assumptions not shown here.
- Partly supported
Every source the paper cites for this claim was checked and supports it.
In the paper
“For all hormone perturbations the time courses of HGP as well as glucose are in good agreement with the experimentally observed changes.”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Role of insulin and glucagon for HGP
What the sources say
- Supportedcites [27] AD Cherrington, 1976, The role of insulin and glucagon in the regulation of basal glucose production in the postabsorptive dog., J Clin Invest source
The Methods describe the hormone perturbations, and the Figure 1–2 captions in the Regulation of Glucose Production by Insulin and Glucagon section identify measured time courses of glucose production and plasma glucose concentration in dogs. The cited paper supplies the experimental observations; the judgment that another set of time courses agrees with them is the citing authors’ own comparison. (LLM, conf=0.85)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Rests on 6 assumptions not shown here.
- Supported
The cited sources support only part of this claim — read each source’s verdict below.
In the paper
“The simulations for glycogen depletion under hypoglycemia (Figure 4A) for glucose concentrations between 3.6 mM (red) and 5 mM (green) are in agreement with experimental data [22], [23].”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > Glycogenolysis in short term fasting
What the sources say
- Not checked — no full text of the sourcecites [22] DL Rothman, 1991, Quantitation of hepatic glycogenolysis and gluconeogenesis in fasting humans with 13C NMR., Science source
- Partly supportedcites [23] I Magnusson, 1992, Increased rate of gluconeogenesis in type II diabetes mellitus. A 13C nuclear magnetic resonance study., J Clin Invest sourceExperimental — accuracy not yet measured
The Results (page not supplied) report a significant decline in liver glycogen during fasting in both diabetic and control subjects. They do not report hypoglycemia at 3.6–5 mM or compare those conditions with the citing paper’s simulations; the reported mean fasting glucose concentrations were 5.1–5.4 mM in controls and higher in diabetic subjects. (LLM, conf=0.87)
plainstates an association- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: passes — The paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
Every source the paper cites for this claim was checked and supports it.
In the paper
“Changes in gene expression play a role in adapting hepatic metabolism on longer time scales to for example reduce futile cycles in counteracting pathways (like down-regulation of glucokinase and up-regulation of glucose-6 phosphatase under hypoglycemia) or match glucose metabolism to physiological requirements (up-regulating of glucose-6 phosphatase under hypoglycemic conditions to increase glucon”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Discussion
What the sources say
- Supportedcites [31] C Vollmers, 2009, Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression., Proc Natl Acad Sci U S A source
The Discussion (“Food Modulated Transcripts Constitute a Metabolic Sand Timer”; page unavailable) reports that hepatic transcripts change with feeding and fasting, with fasting-induced transcripts accumulating as fasting continues. The Results (“Daily Rhythms in Metabolic Regulators”; page unavailable) link these changes to regulators of cellular energy metabolism, supporting the broad claim about gene expression and longer-term metabolic adaptation. (LLM, conf=0.85)
plainstates a cause- Asserted: passes — The authors put it forward as true.
- Checkable: passes — It can be checked against evidence.
- Load-bearing: unclear — It is unclear whether the paper’s conclusions depend on it.
- Based: passes — The paper gives a reason why it holds.
- Supported
74 more claims · 3 with their cited sources checked
Create a free account to see all 141 claims and every source verdict.
- It may state two separate claims as one. 53
- Probably not a substantial claim. 14
- The quote only partly states this claim. 2
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
Each contradiction between two passages listed here was confirmed by an independent check.
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 2H2O | [56] | 10 | 12.2 | 7.4 | 3.8 | 60 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 12.2 · recomputed 11.2
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 2H2O | [67] | 16 | 17.5 | 8.9 | 8.2 | 51 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 17.5 · recomputed 17.1
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 13C-glucose (a) | [58] | 18 | 8.5 | 5.9 | 2.6 | 59 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 59 · recomputed 69.411765
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
“| 13C-glycerol MIDA | [49] | 60 | 7.87 | 7.71 | 1.58 | 98 |”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Methods > Hepatic glucose production, gluconeogenesis and glycogenolysis
Reported 7.87 · recomputed 9.29
Rated minor: it would not touch a result — a value no result rests on, a p-value that stays on the same side of the significance level, or a conflict that is clerical, resolved elsewhere in the paper, or outside its own findings.
In the paper
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results
“Blood glucose is varied between 3.6 mM (red) and 4.6 mM (green) in steps of 0.2 mM.”
§ Quantifying the Contribution of the Liver to Glucose Homeostasis: A Detailed Kinetic Model of Human Hepatic Glucose Metabolism > Results > HGP, gluconeogenesis and glycogenolysis in short term fasting
“The simulations for short term fasting under constant glucose concentrations between 5 mM (green) and 3 mM (red), the normal range of fasting glucose concentration [22], [23], are in agreement with the experimental data (Figure 3, Table 2).”
1 more finding
Create a free account to see every finding of this check.
Citations
Cites
(1993) · New England Journal of Medicine · doi:10.1056/nejm199309303291401 · Cited by 24,667
The Pathobiology of Diabetic Complications
Brownlee, M. (2005) · Diabetes · doi:10.2337/diabetes.54.6.1615 · Cited by 5,339
Role of oxidative stress in diabetic complications: a new perspective on an old paradigm.
Baynes, J. W., & Thorpe, S. R. (1999) · Diabetes · doi:10.2337/diabetes.48.1.1 · Cited by 2,441
Meal Simulation Model of the Glucose-Insulin System
Dalla Man, C., Rizza, R. A., & Cobelli, C. (2007) · IEEE Transactions on Biomedical Engineering · doi:10.1109/tbme.2007.893506 · Cited by 955
Molecular physiology of the regulation of hepatic gluconeogenesis and glycolysis.
Pilkis, S. J., & Granner, D. K. (1992) · Annual Review of Physiology · doi:10.1146/annurev.ph.54.030192.004321 · Cited by 865
Time of feeding and the intrinsic circadian clock drive rhythms in hepatic gene expression.
Vollmers, C., Gill, S., DiTacchio, L., Pulivarthy, S. R., Le, H. D., & Panda, S. (2009) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.0909591106 · Cited by 765 · cited 1×
“is strongly dependent on the external concentration of glucose and to a much lesser extent on the glycogen level. (ii) Under hypoglycemic conditions main control of hepatic glucose metabolism is exerted by a completely different set of reactions than in hyperglycemia. (iii) The response of the opposing pathway couples…”
BackgroundMagnusson, I., Rothman, D. L., Katz, L. D., Shulman, R. G., & Shulman, G. I. (1992) · Journal of Clinical Investigation · doi:10.1172/jci115997 · Cited by 757
Mitrakou, A., Kelley, D., Mokan, M., Veneman, T., Pangburn, T., Reilly, J., & Gerich, J. (1992) · New England Journal of Medicine · doi:10.1056/nejm199201023260104 · Cited by 595
Zonation of parenchymal and nonparenchymal metabolism in liver.
Jungermann, K., & Keitzmann, T. (1996) · Annual Review of Nutrition · doi:10.1146/annurev.nu.16.070196.001143 · Cited by 589 · cited 1×
“A model is always an abstraction of reality describing a certain subset of biological phenomena. The underlining assumptions are crucial for to understand the range of application of the model and the limitations. Main model assumptions and simplifications are (i) usage of phenomenological functions to incorporate hor…”
BackgroundMitrakou, A., Ryan, C., Veneman, T., Mokan, M., Jenssen, T., Kiss, I., Durrant, J., Cryer, P., & Gerich, J. (1991) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.1991.260.1.e67 · Cited by 558
Cited by
Mechanisms of Insulin Action and Insulin Resistance
Petersen, M. C., & Shulman, G. I. (2018) · Physiological Reviews · doi:10.1152/physrev.00063.2017 · Cited by 3,028
Versatile functions for IL-6 in metabolism and cancer
Mauer, J., Denson, J. L., & Brüning, J. C. (2015) · Trends in Immunology · doi:10.1016/j.it.2014.12.008 · Cited by 407
Shestov, A. A., Liu, X., Ser, Z., Cluntun, A. A., Hung, Y. P., Huang, L., Kim, D., Le, A., Yellen, G., Albeck, J. G., et al. (2014) · eLife · doi:10.7554/elife.03342 · Cited by 315
“We first used two independent sets of experimental data from a compendium of steady-state metabolite concentrations of liver cells and steady-state fluxes of DB1 melanoma cells evaluated using a cultured bioreactor (Konig et al., 2012; Shestov et al., 2013).”
MethodGowd, V., Jia, Z., & Chen, W. (2017) · Trends in Food Science & Technology · doi:10.1016/j.tifs.2017.07.015 · Cited by 239
Plasma Sphingosine-1-Phosphate Is Elevated in Obesity
Kowalski, G. M., Carey, A. L., Selathurai, A., Kingwell, B. A., & Bruce, C. R. (2013) · PLoS ONE · doi:10.1371/journal.pone.0072449 · Cited by 175
“For example, a 10 h fast in humans has relatively minor effects on hepatic glycogen content [49,50], while in mice, a 12 h fast results in almost complete depletion of hepatic glycogen [44].”
BackgroundNarasimhan, A., Chinnaiyan, M., & Karundevi, B. (2015) · Applied Physiology, Nutrition, and Metabolism · doi:10.1139/apnm-2015-0002 · Cited by 164
Patra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie International Edition · doi:10.1002/anie.201510551 · Cited by 160
The impact of mathematical modeling on the understanding of diabetes and related complications
Ajmera, I., Swat, M., Laibe, C., Le Novère, N., & Chelliah, V (2013) · CPT: Pharmacometrics & Systems Pharmacology · doi:10.1038/psp.2013.30 · Cited by 153
Hepatic glucose metabolism in the steatotic liver
Scoditti, E., Sabatini, S., Carli, F., & Gastaldelli, A. (2024) · Nature Reviews Gastroenterology & Hepatology · doi:10.1038/s41575-023-00888-8 · Cited by 134
“…the relative contribution of glycogenolysis and gluconeogenesis to HGP shifts from an initial contribution of glycogen-olysis to EGP of 50% after around 12 h of fasting to almost 0% after 40 h of fasting when glycogen stores are exhausted, and glucose is almost totally synthesized de novo 113 .”
Rashid, K., Das, J., & Sil, P. C. (2012) · Food and Chemical Toxicology · doi:10.1016/j.fct.2012.10.007 · Cited by 129
Interoception as modeling, allostasis as control
Sennesh, E., Theriault, J., Brooks, D., van de Meent, J.-W., Barrett, L. F., & Quigley, K. S. (2022) · Biological Psychology · doi:10.1016/j.biopsycho.2021.108242 · Cited by 107
Advancing metabolic models with kinetic information
Link, H., Christodoulou, D., & Sauer, U. (2014) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2014.01.015 · Cited by 117
Rashidian, G., Kajbaf, K., Prokić, M. D., & Faggio, C. (2019) · Fish & Shellfish Immunology · doi:10.1016/j.fsi.2019.12.018 · Cited by 112
Gonçalves, E., Bucher, J., Ryll, A., Niklas, J., Mauch, K., Klamt, S., Rocha, M., & Sáez-Rodríguez, J. (2013) · Molecular BioSystems · doi:10.1039/c3mb25489e · Cited by 109
Ricken, T., Werner, D., Holzhütter, H., König, M., Dahmen, U., & Dirsch, O. (2014) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-014-0619-z · Cited by 102
“The important role of glycogen as glucose buffer is underlined, with glycogen storage under hyperglycemic conditions and glycogenolysis when blood glucose values fall (König et al. 2012; Nuttal et al. 2008; Radziuk and Pye 2001; Wahren and Ekberg 2007).”
InfluentialSelf-citationGlucose and glycogen in the diabetic kidney: Heroes or villains?
Sullivan, M. A., & Forbes, J. M. (2019) · EBioMedicine · doi:10.1016/j.ebiom.2019.07.067 · Cited by 88
“involves complex enzymatic cascades which are not detailed here but can be found in these reviews [34,35].”
BackgroundMagnetic resonance imaging of glycogen using its magnetic coupling with water
Zhou, Y., van Zijl, P. C. M., Xu, X., Xu, J., Li, Y., Chen, L., & Yadav, N. N. (2020) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.1909921117 · Cited by 77
Ameliorative effects of taurine against diabetes: a review
Inam-u-llah, Piao, F., Aadil, R. M., Suleman, R., Li, K., Zhang, M., Wu, P., Shahbaz, M., & Ahmed, Z. (2018) · Amino Acids · doi:10.1007/s00726-018-2544-4 · Cited by 78
“2009a, b) because of the unique task of the liver in glucose metabolism (König et al. 2012).”
BackgroundA blueprint for human whole-cell modeling
Szigeti, B., Roth, Y. D., Sekar, J. A. P., Goldberg, A. P., Pochiraju, S. C., & Karr, J. R. (2018) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.10.005 · Cited by 72
Berndt, N., Bulik, S., Wallach, I., Wünsch, T., König, M., Stockmann, M., Meierhofer, D., & Holzhütter, H. (2018) · Nature Communications · doi:10.1038/s41467-018-04720-9 · Cited by 73
“Single pathways as defined in biochemical text books are numbered and highlighted by different coloring: (1) glycogen metabolism, (2) fructose metabolism, (3) galactose metabolism, (4) glycolysis, (5) gluconeogenesis, (6) oxidative pentose phosphate pathway, (7) non-oxidative pentose phosphate pathway, (8) fatty acid…”
BackgroundSelf-citationGreen Fluorescent Protein-Based Glucose Indicators Report Glucose Dynamics in Living Cells
Mita, M., Ito, M., Harada, K., Sugawara, I., Ueda, H., Tsuboi, T., & Kitaguchi, T. (2019) · Analytical Chemistry · doi:10.1021/acs.analchem.9b00447 · Cited by 65
Yang, G., Cao, H., Jiang, W., Hu, B., Jian, S., Wen, C., Kajbaf, K., Kumar, V., Tao, Z., & Peng, M. (2019) · Aquaculture Research · doi:10.1111/are.14102 · Cited by 63
Kumar, V., Sharma, K., Ahmed, B., Al-Abbasi, F. A., Anwar, F., & Verma, A. (2018) · RSC Advances · doi:10.1039/c7ra12568b · Cited by 66
Nishino, T., Yachie‐Kinoshita, A., Hirayama, A., Soga, T., Suematsu, M., & Tomita, M. (2013) · PLoS ONE · doi:10.1371/journal.pone.0071060 · Cited by 59
“Detailed mathematical models are useful to analyze complex metabolic regulations in functional organs, tissues, and cells [7,8].”
BackgroundComputational Strategies for a System-Level Understanding of Metabolism
Cazzaniga, P., Damiani, C., Besozzi, D., Colombo, R., Nobile, M. S., Gaglio, D., Pescini, D., Molinari, S., Mauri, G., Alberghina, L., et al. (2014) · Metabolites · doi:10.3390/metabo4041034 · Cited by 67
“On a larger scale, a comprehensive kinetic model of human hepatic glucose metabolism was presented in [157].”
BackgroundSeal, S. V., & Turner, J. D. (2021) · International Journal of Molecular Sciences · doi:10.3390/ijms22073344 · Cited by 68
Scientific Opinion on the essential composition of total diet replacements for weight control
EFSA Panel on Dietetic Products, N. A. A. (. (2015) · EFSA Journal · doi:10.2903/j.efsa.2015.3957 · Cited by 66
“…glucose production upon prolonged fasting is about 1.5 mg/kg per minute, with liver gluconeogenesis contributing almost all of glucose production (Landau et al., 1996; Chandramouli et al., 1997; Hellerstein et al., 1997), which is also in agreement with the model proposed by König et al. (2012).”
ResultInfluentialKalinovich, A., Dehvari, N., Åslund, A., van Beek, S., Halleskog, C., Olsen, J., Forsberg, E., Zacharewicz, E., Schaart, G., Rinde, M., et al. (2020) · Diabetologia · doi:10.1007/s00125-020-05171-y · Cited by 54
Gut microbes and the liver circadian clock partition glucose and lipid metabolism
Frazier, K., Manzoor, S. S., Carroll, K., DeLeon, O., Miyoshi, S., Miyoshi, J., George, M. S., Tan, A., Chrisler, E. A., Izumo, M., et al. (2023) · Journal of Clinical Investigation · doi:10.1172/jci162515 · Cited by 59
“Circadian disruption is linked to metabolic syndrome (4), and glucose dysregulation is a hallmark of the disease (5, 6).”
BackgroundTargeting pathogen metabolism without collateral damage to the host
Haanstra, J. R., Gerding, A., Dolga, A. M., Sorgdrager, F. J. H., Buist‐Homan, M., du Toit, F., Faber, K. N., Holzhütter, H., Szöőr, B., Matthews, K. R., et al. (2017) · Scientific Reports · doi:10.1038/srep40406 · Cited by 50
“Earlier analyses of this model had shown that the hepatic glucose transporter GLUT2 exerted no flux control over a range of glucose concentrations 33 , suggesting that hepatocytes are not vulnerable to glucose transport inhibition.”
Self-citationFromentin, C., Tomé, D., Nau, F., Flet, L., Luengo, C., Azzout‐Marniche, D., Sandérs, P., Fromentin, G., & Gaudichon, C. (2012) · Diabetes · doi:10.2337/db12-1208 · Cited by 55
Ashworth, W. B., Davies, N. A., & Bogle, I. D. L. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1005105 · Cited by 54
“developed a detailed model of enzymatic conversions in glucose homeostasis including much of the allosteric regulation known to occur in glucose regulation [46].”
BackgroundZhang, Z., Sun, Z., Xiao, X., Zhou, S., Wang, X., Gu, J., Qiu, L., Zhang, X., Xu, Q., Zhen, B., et al. (2013) · Archives of Toxicology · doi:10.1007/s00204-013-1059-8 · Cited by 48
“Hyperglycemia results in nonenzymatic glycosylation and thus lossof-function of proteins (Papin et al. 2012).”
Christ, B., Collatz, M., Dahmen, U., Herrmann, K., Höpfl, S., König, M., Lambers, L., Marz, M., Meyer, D., Radde, N. E., et al. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.733868 · Cited by 48
“Genome-scale models of hepatic metabolism using a constraint-based approach exist (Gille et al., 2010; Mardinoglu et al., 2014) as do detailed kinetic models of central carbon metabolism (Berndt et al., 2018) or glycolysis (König and Holzhütter, 2012; König et al., 2012).”
MethodSelf-citationThe potential for a carbon stable isotope biomarker of dietary sugar intake
Jahren, A. H., Bostic, J. N., & Davy, B. M. (2014) · Journal of Analytical Atomic Spectrometry · doi:10.1039/c3ja50339a · Cited by 51
Vaccarin ameliorates insulin resistance and steatosis by activating the AMPK signaling pathway
Lei, Y., Gong, L., Tan, F., Liu, Y., Li, S., Shen, H., Zhu, M. P., Cai, W., Xu, F., Hou, B., et al. (2019) · European Journal of Pharmacology · doi:10.1016/j.ejphar.2019.02.029 · Cited by 45
Bulik, S., Holzhütter, H.-G., & Berndt, N. (2016) · BMC Biology · doi:10.1186/s12915-016-0237-6 · Cited by 45
“[6], we established an empirical GHT function, which describes the relationship between the plasma level of glucose and of insulin and glucagon.”
Self-citationGlucose monitoring in living cells with single fluorescent protein-based sensors
Hu, H., Wei, Y., Wang, D., Su, N., Chen, X., Zhao, Y., Liu, G., & Yang, Y. A. (2018) · RSC Advances · doi:10.1039/c7ra11347a · Cited by 47
Rhodiola crenulata extract suppresses hepatic gluconeogenesis via activation of the AMPK pathway
Lee, S., Lai, F.-Y., Shi, L.-S., Chou, Y., Yen, I., & Chang, T. (2015) · Phytomedicine · doi:10.1016/j.phymed.2015.01.016 · Cited by 45
Geniposide and Gentiopicroside Suppress Hepatic Gluconeogenesis via Regulation of AKT-FOXO1 Pathway
Yang, S., Chen, Y.-D., Li, H., Hui, X., & Gao, W. (2018) · Archives of Medical Research · doi:10.1016/j.arcmed.2018.10.005 · Cited by 44
Rites of passage: requirements and standards for building kinetic models of metabolic phenotypes
Mišković, L., Tokić, M. S., Fengos, G., & Vassily Hatzimanikatis, A. (2015) · Current Opinion in Biotechnology · doi:10.1016/j.copbio.2015.08.019 · Cited by 41
“There are attempts to reduce complexity either by combining kinetic and stoichiometric models [25,43], or by considering the concentrations of co-factors and small molecules such as CO2 and phosphate as constant in the rate expressions [54,58].”
BackgroundInfluentialThe virtual liver: state of the art and future perspectives
Drasdo, D., Bode, J. G., Dahmen, U., Dirsch, O., Dooley, S., Gebhardt, R., Ghallab, A., Godoy, P., Häussinger, D., Hammad, S., et al. (2014) · Archives of Toxicology · doi:10.1007/s00204-014-1384-6 · Cited by 39
“The contribution of liver metabolism to the homeostasis of the plasma glucose level was investigated on the basis of a comprehensive kinetic model of hepatic glucose metabolism (König et al. 2012; König and Holzhütter 2012).”
MethodSelf-citationA pathway model of glucose-stimulated insulin secretion in the pancreatic β-cell
Maheshvare, M. D., Raha, S., König, M., & Pal, D. (2023) · Frontiers in Endocrinology · doi:10.3389/fendo.2023.1185656 · Cited by 57
“f a = o Css(da i )Css(da i ) o(C(d i ))(2) (2)”
BackgroundSelf-citationPatra, M., Johnstone, T. C., Suntharalingam, K., & Lippard, S. J. (2016) · Angewandte Chemie · doi:10.1002/ange.201510551 · Cited by 43
Development of red genetically encoded biosensor for visualization of intracellular glucose dynamics
Mita, M., Sugawara, I., Harada, K., Ito, M., Takizawa, M., Ishida, K., Ueda, H., Kitaguchi, T., & Tsuboi, T. (2021) · Cell chemical biology · doi:10.1016/j.chembiol.2021.06.002 · Cited by 39
Somvanshi, P. R., Mellon, S. H., Flory, J. D., Abu-Amara, D., PTSD Systems Biology Consortium;, Wolkowitz, O. M., Yehuda, R., Jett, M., Hood, L., Marmar, C., et al. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00065.2019 · Cited by 43
Metabolic and Epigenetic Action Mechanisms of Antidiabetic Medicinal Plants
Shanak, S., Saad, B., & Zaid, H. (2019) · Evidence-based Complementary and Alternative Medicine · doi:10.1155/2019/3583067 · Cited by 50
“5mM) [25], balance should be maintained between the rate of glucose entering the bloodstream (glucose appearance) and glucose removed from the circulation (glucose disappearance).”
BackgroundCao, G., Dai, B., Wang, K. L., et al. (2019) · Journal of Applied Microbiology · doi:10.1111/jam.14352 · Cited by 40
Computational Modeling in Liver Surgery
Christ, B., Dahmen, U., Herrmann, K., König, M., Reichenbach, J. R., Ricken, T., Schleicher, J., Schwen, L. O., Vlaic, S., & Waschinsky, N. (2017) · Frontiers in Physiology · doi:10.3389/fphys.2017.00906 · Cited by 41
“(König et al., 2012).”
InfluentialSelf-citationMechanistic Modeling and Multiscale Applications for Precision Medicine: Theory and Practice
Stalidzāns, E., Zanin, M., Tieri, P., Castiglione, F., Polster, A. V., Scheiner, S., Pahle, J., Stres, B., List, M., Baumbach, J., et al. (2020) · Network and Systems Medicine · doi:10.1089/nsm.2020.0002 · Cited by 44
Digital twin predicting diet response before and after long-term fasting
Silfvergren, O., Simonsson, C., Ekstedt, M., Lundberg, P., Gennemark, P., & Cedersund, G. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010469 · Cited by 42
“Some other related previous models have instead focused on the detailed metabolism of the liver [45–47], but such models have had no realistic meal response part.”
BackgroundZaborska, K. E., Dadi, P. K., Dickerson, M. T., Nakhe, A. Y., Thorson, A. S., Schaub, C. M., Graff, S. M., Stanley, J. E., Kondapavuluru, R. S., Denton, J. S., et al. (2020) · Molecular Metabolism · doi:10.1016/j.molmet.2020.101056 · Cited by 35
Protective Mechanisms of Hypothermia in Liver Surgery and Transplantation
Olthof, P. B., Reiniers, M. J., Dirkes, M. C., van Gulik, T. M., Heger, M., & van Golen, R. F. (2015) · Molecular Medicine · doi:10.2119/molmed.2015.00158 · Cited by 43
Nutrition Research and the Impact of Computational Systems Biology
Auley, M. T. M. (2013) · Journal of Computer Science & Systems Biology · doi:10.4172/jcsb.1000122 · Cited by 38
“The modelling of nutrient-centred biochemical pathways with the ODE approach has been extremely useful to the field of nutrition [50-57].”
MethodBerndt, N., Horger, M., Bulik, S., & Holzhütter, H. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006005 · Cited by 39
Self-citationMatović, J., Järvinen, J., Bland, H. C., Sokka, I. K., Imlimthan, S., Ferrando, R. M., Huttunen, K. M., Timonen, J. M., Peräniemi, S., Aitio, O., et al. (2020) · Molecular Pharmaceutics · doi:10.1021/acs.molpharmaceut.0c00630 · Cited by 31
Virtual metabolic human dynamic model for pathological analysis and therapy design for diabetes
Kurata, H. (2021) · iScience · doi:10.1016/j.isci.2021.102101 · Cited by 29
Drug target identification through systems biology
Haanstra, J. R., & Bakker, B. M. (2015) · Drug Discovery Today Technologies · doi:10.1016/j.ddtec.2015.06.002 · Cited by 30
Tummler, K., & Klipp, E. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.11.003 · Cited by 30
Gaetano, A. D., & Hardy, T. A. (2019) · PLoS ONE · doi:10.1371/journal.pone.0222833 · Cited by 30
“Glucagon plasma concentration has also been shown to increase above some minimum (determined by some measure of continuous production), in an exponentially increasing fashion as glycemia decreases: a large set of experimental data were fitted to show this relationship [56].”
BackgroundHypoglycemia Begets Hypoglycemia: The Order Effect in the ASPIRE In-Clinic Study
Garg, S. K., Brazg, R., Bailey, T. S., Buckingham, B. A., Slover, R. H., Klonoff, D. C., Shin, J., Welsh, J. B., & KAUFMAN, F. R. (2014) · Diabetes Technology & Therapeutics · doi:10.1089/dia.2013.0219 · Cited by 31
“When basal insulin delivery is suspended during hypo-glycemia, the liver and sympathoadrenal system play critical roles in the timing and magnitude of recovery, and a detailed mathematical model of hepatic glucose metabolism 13 suggests a multifaceted etiology for the order effect.”
Parastesh, M., Zadeh, E. K., Saremi, A., & Ahoora, R. (2019) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-019-00422-1 · Cited by 30
König, M., & Holzhütter, H. (2012) · Journal of Biological Chemistry · doi:10.1074/jbc.m112.382069 · Cited by 27
“Glycogenolysis andGlycogen Synthesis inT2DM—Inaddition to data for normal glucose metabolism (18), data for subjects with T2DM (supplemental Table S1) were extracted from (22).”
BackgroundMethodInfluentialSelf-citationSun, S., Wei, X., Zhou, X., & You, C. (2020) · Journal of Agricultural and Food Chemistry · doi:10.1021/acs.jafc.0c06936 · Cited by 27
Hoehme, S., Hammad, S., Boettger, J., Begher‐Tibbe, B., Bucur, P. O., Vibert, É., Gebhardt, R., Hengstler, J. G., & Drasdo, D. (2022) · iScience · doi:10.1016/j.isci.2022.105714 · Cited by 29
Yusoff, N. A., Lim, V., Al-Hindi, B., Razak, K. N. A., Widyawati, T., Anggraini, D. R., Ahmad, M., & Asmawi, M. Z. (2017) · Nutrients · doi:10.3390/nu9090925 · Cited by 31
“This role is due to its capability to control hepatic glucose production via two ways: The release of newly synthesized glucose in the blood stream during the fasting state; and the utilization and storage of glucose when glucose is elevated during the feeding state [36,37].”
BackgroundYoung, C. K. J., & Young, M. J. (2019) · Cell Cycle · doi:10.1080/15384101.2019.1578133 · Cited by 26
“Following supplement additions to Williams' E Medium to make either WGM or WDM the final glucose concentrations were ~10 mM, which is similar to the human postprandial plasma level of ~9 mM (44).”
MethodAzevedo, L. F., Carneiro, M. F. H., Dechandt, C. R. P., Cassoli, J. S., Alberici, L. C., & Barbosa, F. (2019) · Environmental Research · doi:10.1016/j.envres.2019.109080 · Cited by 27
Gena, P., Buono, N. D., D’Abbicco, M., Mastrodonato, M., Berardi, M., Svelto, M., Lopez, L., & Calamita, G. (2016) · European Journal of Cell Biology · doi:10.1016/j.ejcb.2016.12.003 · Cited by 25
The application of lactose in sports nutrition
Odell, O. J., & Wallis, G. A. (2020) · International Dairy Journal · doi:10.1016/j.idairyj.2020.104970 · Cited by 26
Sarkar, J., Dwivedi, G., Chen, Q., Sheu, I. E., Paich, M., Chelini, C. M., D'Alessandro, P. M., & Burns, S. P. (2018) · PLoS ONE · doi:10.1371/journal.pone.0192472 · Cited by 22
Design principles of the paradoxical feedback between pancreatic alpha and beta cells
Garzilli, I., & Itzkovitz, S. (2018) · Scientific Reports · doi:10.1038/s41598-018-29084-4 · Cited by 29
Detection of Human Plasma Glucose Using a Self-Powered Glucose Biosensor
Slaughter, G. E., & Kulkarni, T. (2019) · Energies · doi:10.3390/en12050825 · Cited by 21
“Clinically relevant plasma glucose concentration below 5 mM is considered to be hypoglycemia and above 7.5 mM is considered to be hyperglycemia [7].”
BackgroundInfluentialNyman, E., Wesseling-Rozendaal, Y. J. W., Helmlinger, G., Hamrén, B., Kjellsson, M. C., Strålfors, P., van Riel, N. A. W., Gennemark, P., & Cedersund, G. (2016) · Interface Focus · doi:10.1098/rsfs.2015.0075 · Cited by 22
“This metabolism has been modelled using data from multiple clinical studies, on acute glucose response to changes in these hormones [26].”
MethodHerrgårdh, T., Li, H., Nyman, E., & Cedersund, G. (2021) · Frontiers in Physiology · doi:10.3389/fphys.2021.619254 · Cited by 23
“A version of this model, trained on data from patients with type 1 diabetes, is approved by the Food and Drug Administration, FDA, for replacement of animal experiments in the approval of the algorithm inside new insulin pumps (Kovatchev et al., 2009).”
MethodVerma, A., Pathak, P., Rimac, H., Khalilullah, H., Kumar, V., Grishina, M., Potemkin, V., & Ahmed, B. (2021) · Biocatalysis and Agricultural Biotechnology · doi:10.1016/j.bcab.2021.102138 · Cited by 22
Ryll, A., Bucher, J., Bonin, A., Bongard, S., Gonçalves, E., Sáez-Rodríguez, J., Niklas, J., & Klamt, S. (2014) · Biosystems · doi:10.1016/j.biosystems.2014.07.002 · Cited by 21
In vivo and in silico dynamics of the development of Metabolic Syndrome
Wesseling-Rozendaal, Y. J. W., Wang, Y., Paalvast, Y., Tambyrajah, L. L., Li, Z., van Dijk, K. W., Rensen, P. C. N., Kuivenhoven, J. A., Groen, A. K., Hilbers, P. A. J., et al. (2018) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1006145 · Cited by 20
Kuzgun, G., Başaran, R., Arioglu‐Inan, E., & Eke, B. C. (2020) · Journal of Diabetes & Metabolic Disorders · doi:10.1007/s40200-020-00616-y · Cited by 20
Network Biology Approaches to Achieve Precision Medicine in Inflammatory Bowel Disease
Thomas, J. P., Módos, D., Korcsmáros, T., & Brooks-Warburton, J. (2021) · Frontiers in Genetics · doi:10.3389/fgene.2021.760501 · Cited by 23
“Forillustration,the glucose metabolism was used from Köenig et al., 2012 (König et al., 2012). intraepithelial lymphocytes (IELs) and CD8 + IL17 + T cells.”
MethodHepatoDyn: A Dynamic Model of Hepatocyte Metabolism That Integrates 13C Isotopomer Data
Foguet, C., Marín, S., Selivanov, V. A., Fanchon, É., Lee, W. P., Guinovart, J. J., de Atauri, P., & Cascante, M. (2016) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1004899 · Cited by 20
“Due to this complexity, kinetic models of hepatocyte metabolism available in the literature contain only a small number of reactions and, with some exceptions [11], are often limited to a single pathway.”
BackgroundMethodTeng, J.-F., Lee, C., Hsu, T., & Lo, H. (2018) · PLoS ONE · doi:10.1371/journal.pone.0201131 · Cited by 20
Computational Modeling of Glucose Uptake in the Enterocyte
Afshar, N., Safaei, S., Nickerson, D. P., Hunter, P. J., & Suresh, V. (2019) · Frontiers in Physiology · doi:10.3389/fphys.2019.00380 · Cited by 16
“At the cellular level, models of glucose uptake and transport in the kidneys (Weinstein, 2015), glucose homeostasis in the liver (König et al., 2012), and glucose sensing (Riz and Pedersen, 2015) have been developed.”
BackgroundDickerson, M. T., Dadi, P. K., Altman, M. K., Verlage, K. R., Thorson, A. S., Jordan, K. L., Vierra, N. C., Amarnath, G., & Jacobson, D. A. (2019) · American Journal of Physiology-Endocrinology and Metabolism · doi:10.1152/ajpendo.00342.2018 · Cited by 18
Connecting signaling and metabolic pathways in EGF receptor-mediated oncogenesis of glioblastoma
Bag, A. K., Mandloi, S., Jarmalavicius, S., Mondal, S., Kumar, K. G., Mandal, C., Walden, P., Chakrabarti, S., & Mandal, C. (2019) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1007090 · Cited by 18
Li, C., Gan, H. T., Tan, X., Hu, Z., Deng, B., Sullivan, M. A., & Gilbert, R. G. (2018) · European Polymer Journal · doi:10.1016/j.eurpolymj.2018.12.039 · Cited by 17
Somvanshi, P. R., Tomar, M., & Kareenhalli, V. V. (2019) · Scientific Reports · doi:10.1038/s41598-019-50889-4 · Cited by 18
Kinetic modeling of glucose central metabolism in hepatocytes and hepatoma cells
Marín‐Hernández, Á., Gallardo‐Pérez, J. C., Reyes‐García, M. A., Sosa‐Garrocho, M., Macías‐Silva, M., Rodríguez‐Enríquez, S., Moreno‐Sánchez, R., & Saavedra, E. (2020) · Biochimica et Biophysica Acta (BBA) - General Subjects · doi:10.1016/j.bbagen.2020.129687 · Cited by 17
Synthesis and Evaluation of Novel Oleanolic Acid Derivatives as Potential Antidiabetic Agents
Zhang, L., Jia, X., Dong, J., et al. (2013) · Chemical Biology & Drug Design · doi:10.1111/cbdd.12241 · Cited by 16
“When plasma glucose levels are high, the liver takes up glucose, replenishes depleted glycogen stores, thus helping to dampen variations in blood glucose (1).”
BackgroundRamos, J. R. C., Rath, A., Genzel, Y., Sandig, V., & Reichl, U. (2020) · Biotechnology and Bioengineering · doi:10.1002/bit.27288 · Cited by 15
Stochastic Simulation of Cellular Metabolism
Clement, E. J., Schulze, T. T., Soliman, G. A., Wysocki, B. J., Davis, P. H., & Wysocki, T. A. (2020) · IEEE Access · doi:10.1109/access.2020.2986833 · Cited by 17
Kelly, R. A., Leedale, J., Harrell, A., Beard, D. A., Randle, L. E., Chadwick, A. E., & Webb, S. D. (2018) · PLoS ONE · doi:10.1371/journal.pone.0207803 · Cited by 16
Computational Modeling of Fructose Metabolism and Development in NAFLD
Liao, Y., Davies, N. A., & Bogle, I. D. L. (2020) · Frontiers in Bioengineering and Biotechnology · doi:10.3389/fbioe.2020.00762 · Cited by 17
“Relevant in silico simulations have been reported, including glucose absorption and transportation, hormonal regulation, zonation effects, and the relationship between glucose intake and highintensity exercise, lipid metabolism in addition to metabolic diseases (Chalhoub et al., 2007a,b; Hetherington et al., 2012; Kön…”
BackgroundMartín-Bernabé, A., Balcells, C., Tarragó‐Celada, J., Foguet, C., Bourgoin‐Voillard, S., Seve, M., & Cascante, M. (2017) · Current Opinion in Systems Biology · doi:10.1016/j.coisb.2017.05.011 · Cited by 19
Casas, B., Vilén, L., Bauer, S., Kanebratt, K. P., Huldt, C. W., Magnusson, L. U., Marx, U., Andersson, T. B., Gennemark, P., & Cedersund, G. (2022) · PLoS Computational Biology · doi:10.1371/journal.pcbi.1010587 · Cited by 13
“glycogen synthesis and de novo lipogenesis) [3,50].”
Lambers, L., Waschinsky, N., Schleicher, J., König, M., Tautenhahn, H., Albadry, M., Dahmen, U., & Ricken, T. (2024) · Biomechanics and Modeling in Mechanobiology · doi:10.1007/s10237-023-01797-0 · Cited by 13
“Further information about the glucose metabolism is provided in Ricken et al. (2015) and König et al. (2012), information on the fat metabolism in Schleicher et al. (2017).”
Self-citationKönig, M., Holzhütter, H., & Berndt, N. (2013) · Biotechnology Journal · doi:10.1002/biot.201200393 · Cited by 13
Self-citationPedersen, C., Bouman, S. D., Porsgaard, T., ROSENKILDE, M. M., & Roed, N. K. (2018) · Physiological Reports · doi:10.14814/phy2.13657 · Cited by 12
Liver function as an engineering system
Ashworth, W., Pérez-Galván, C., Davies, N. A., & Bogle, I. D. L. (2016) · AIChE Journal · doi:10.1002/aic.15292 · Cited by 14
Ricken, T., Waschinsky, N., & Werner, D. (2017) · Lecture notes in applied and computational mechanics · doi:10.1007/978-3-319-59548-1_2 · Cited by 12
Metadata
- Authors
- König, M., Bulik, S., & Holzhütter, H.-G.
- Affiliations
- Charité – Universitätsmedizin Berlin (DE)
- Corresponding author
- König, Matthias
- Venue
- PLoS Computational Biology
- Publisher
- Public Library of Science (PLoS)
- Published
- 2012-06-21
- Volume
- 8
- Issue
- 6
- Pages
- e1002577
- ISSN
- 1553-734X (ISSN-L)
- 1553-7358
- PMC
- PMC3383054
- OpenAlex
- W2019692827
- Semantic Scholar
- e736ceaff2e762e4127c5127aec4d667b24b6ace
- Cited by
- 202
- References
- 73
- Citations by year
- 2026: 5 · 2025: 10 · 2024: 14 · 2023: 8 · 2022: 18 · 2021: 14 · 2020: 20 · 2019: 24 · 2018: 22 · 2017: 14 · 2016: 10 · 2015: 10 · 2014: 16 · 2013: 13 · 2012: 4
- FWCI
- 5.65
- Type
- journal article
- Language
- en
- Open access
- gold
- doi.org
- Locations
- PLoS Computational Biology (publishedVersion, cc-by)
- Europe PMC (PubMed Central) (publishedVersion, cc-by)
- PubMed Central (publishedVersion, cc-by)
- PubMed (publishedVersion)
- DOAJ (DOAJ: Directory of Open Access Journals) (submittedVersion, cc-by-sa)
- Figshare (submittedVersion, cc-by)
- Topics
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Molecular Biology › Metabolism, Diabetes, and Cancer
- Health Sciences › Medicine › Endocrinology, Diabetes and Metabolism › Pancreatic function and diabetes
- Life Sciences › Biochemistry, Genetics and Molecular Biology › Biochemistry › Glycogen Storage Diseases and Myoclonus
- Keywords
- hepatic glucose metabolism, glucose homeostasis, kinetic model, hepatocytes, glycolysis, gluconeogenesis, glycogen metabolism, insulin, glucagon, epinephrine, hepatic glucose production, hepatic glucose utilization, glycogen storage, hypoglycemia, hyperglycemia, diabetes mellitus, glycogen storage disease
- MeSH terms
- Computer Simulation, Fasting, Glucagon, Gluconeogenesis, Glucose, Homeostasis, Humans, Hyperglycemia, Hypoglycemia, Insulin, Kinetics, Liver, Liver Glycogen, Models, Biological, Computational Biology, Postprandial Period, Glycogenolysis
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
The claim verdicts this report counts are experimental: their accuracy is not yet measured.
A language model drew the claims from the paper on 2026-10-10, under version 3 of the claim definition (model deepseek-v4.1-flash, prompt extract-v3).
A second model labelled each claim on 2026-10-10 (model jev-1.13-20260917, definition revision gold-guideline-v0.2).
Cited sources are checked with a language model’s help (gpt-6-sol).
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.